FDA Import Refusal SCS-6677742-0/31/1 — Ursapharm Arzneimittel GmbH
The FDA refused shipment SCS-6677742-0/31/1 from Ursapharm Arzneimittel GmbH (Germany) on Nov 12, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,2280,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 12, 2024
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,2280,3280